Recessive, pathogenic AARS1 variants display variable loss-of-function and dominant-negative effects
Disease Models & Mechanisms · 2025
DOI: 10.1242/dmm.052006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2025. Verfasst von Molly E Kuo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Loss of Function Mutation, Genes, Recessive, Genes, Dominant, Alanine-tRNA Ligase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, University of Michigan.
Abstract (Originalsprache)
Alanyl-tRNA synthetase 1 (AARS1) has been implicated in multi-system recessive phenotypes and in later-onset dominant neuropathy; to date, no single variant has been associated with both dominant and recessive diseases, raising questions about shared mechanisms between the two inheritance patterns. AARS1 variants associated with recessive disease result in loss-of-function or hypomorphic alleles, and this has been demonstrated, in part, via yeast complementation assays. However, pathogenic alleles have not been assessed in a side-by-side study. Here, we employed a humanized yeast model to evaluate the functional consequences of all AARS1 missense variants reported in recessive disease. The majority of variants showed variable loss-of-function effects, ranging from no growth to significantly reduced growth. These data deem yeast a reliable model to test the effects of AARS1 variants; however, our data also indicate that this model is prone to false-negative results and is not informative for genotype–phenotype studies. We next tested missense variants associated with no growth for dominant-negative effects. Interestingly, K81T and E99G AARS1 demonstrated both loss-of-function and dominant-negative effects, indicating that certain AARS1 variants can cause both dominant and recessive disease phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, University of Michigan, Ann Arbor, MI 48109, USA.
- Medical Scientist Training Program, University of Michigan, Ann Arbor, MI 48109, USA.
- Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- University of Michigan
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Kuo, M. E., Jonatzke, K. E., Parish, M., & Antonellis, A. (2025). Recessive, pathogenic AARS1 variants display variable loss-of-function and dominant-negative effects. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052006
Vancouver
Kuo ME, Jonatzke KE, Parish M, Antonellis A. Recessive, pathogenic AARS1 variants display variable loss-of-function and dominant-negative effects. Disease Models & Mechanisms. 2025. doi:10.1242/dmm.052006
BibTeX
@article{Kuo2025,
author = {Kuo, Molly E and Jonatzke, Kira E and Parish, Maclaine and Antonellis, Anthony},
title = {Recessive, pathogenic AARS1 variants display variable loss-of-function and dominant-negative effects},
journal = {Disease Models & Mechanisms},
year = {2025},
doi = {10.1242/dmm.052006}
}
EUVIMED